GeneTex engages CRISPR/Cas9 technology to validate antibody specificity. One of GeneTex's immediate goals is to integrate CRISPR/Cas9 technology into their quality assurance process as the “knockout” arm of their antibody specificity validation efforts. Read this article to learn more about how GeneTex is using CRISPR/Cas9 technology to confirm target specificity of their antibodies.
Read Article